What Policy is Effective to Decrease Drug Use in America?

Hear a discussion with Dr. Bertha Madras on High Truths on Drugs and Addiction, Episode #12.

Dr. Madras is an IASIC scientific advisor, Harvard Professor and former White House Office of National Drug Control Policy Deputy Director of Demand Reduction. In episode #12, Dr. Madras explains the importance and possible prevention of drug use. The current climate of marijuana legalization and normalizing drug use is creating a pipeline of increased addiction. The cure for the disease of addiction comes from prevention. Treatment of addiction is critical, but prevention is key. The same goes for any disease process. The cure to the COVID-19 pandemic is the vaccine. Treating COVID pneumonia is important, but the key to the cure lays in prevention.

Click here to listen now.

About Dr. Bertha Madras
Dr. Bertha K. Madras is Professor of Psychobiology, Department of Psychiatry at Harvard Medical School (HMS). She developed and chaired the Division of Neurochemistry at the HMS-NEPRC. A neuroscientist, her research focuses on addiction biology and neuropsychiatric disease. Her work is reported in over 150 manuscripts and book chapters. She is the principal or co-editor of four. In public policy, she served as Deputy Director for Demand Reduction in the White House Office of National Drug Control Policy (ONDCP). At ONDCP, she advocated for the medicalization of the diagnosis and treatment of substance use disorders. She mainstreamed Drug and Alcohol Screening, Brief Intervention, Referral to Treatment (SBIRT) in healthcare systems as a component of the national drug control strategy. She also spearheaded approval of billing codes for these services resulting in reimbursement by Medicaid and health insurers, adoption by federal agencies. Her experiences in research, brain biology, education, government and public service offer her a unique perspective on public policy, brain science and public education.

Listen to Episode #12 Now

For more information on the International Academy on the Science and Impact of Cannabis, and to join, please visit www.IASIC1.org.

Visit the IASIC Library here. The IASIC Library is intended as a user-friendly reference of the published medical literature.

Like this article?

Share on Facebook
Share on Twitter
Share on Linkdin
Share on Pinterest

Related Posts

IASIC Speaker Series Presents: Impacts of Maternal Cannabis Use on Long-Term Psychiatric Risk

The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed,

Libby Stuyt Interview on Randy Tobler show

Exciting News! Libby Stuyt’s Interview on Randy Tobler Show! Hey everyone, we wanted to share some thrilling news! The brilliant Dr. Libby Stuyt recently had an enlightening interview on Randy Tobler Show. Dr. Stuyt is known for her groundbreaking work in the field of addiction medicine and mental health. Her insights are nothing short of

Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies

Introduction Cannabis contains over 100 cannabinoids, of which Δ9-tetrahydrocannabinol and cannabidiol are the most clinically relevant. Tetrahydrocannabinol is a partial agonist at CB1 and binds CB2 receptors. CB1 is widely expressed by central and peripheral neurones but also by immune cells and other type of cells in the brain and in the periphery, and when

Medical marijuana access and prolonged opioid use among adolescents and young adults

Abstract Background and Objectives Laws liberalizing access to medical marijuana are associated with reduced opioid analgesic use among adults, but little is known about the impact of such policies on adolescents and young adults. Methods This retrospective cohort study used 2005 to 2014 claims from MarketScan® Commercial database, which covers all 50 states and Washington

Scroll to Top